Qtron Investments LLC Makes New $413,000 Investment in Clorox Co (NYSE:CLX)

Qtron Investments LLC bought a new stake in Clorox Co (NYSE:CLX) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,575 shares of the company’s stock, valued at approximately $413,000.

Several other institutional investors also recently modified their holdings of CLX. BlackRock Inc. raised its position in Clorox by 0.8% during the 1st quarter. BlackRock Inc. now owns 10,639,351 shares of the company’s stock worth $1,707,189,000 after buying an additional 83,514 shares during the last quarter. Oregon Public Employees Retirement Fund increased its holdings in shares of Clorox by 48,033.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock valued at $44,000 after purchasing an additional 6,794,834 shares in the last quarter. Northern Trust Corp increased its holdings in shares of Clorox by 3.4% in the 1st quarter. Northern Trust Corp now owns 2,355,067 shares of the company’s stock valued at $377,894,000 after purchasing an additional 76,799 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Clorox by 21.5% in the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after purchasing an additional 335,835 shares in the last quarter. Finally, Janus Henderson Group PLC increased its holdings in shares of Clorox by 28.4% in the 1st quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock valued at $284,204,000 after purchasing an additional 391,569 shares in the last quarter. Institutional investors and hedge funds own 77.56% of the company’s stock.

CLX has been the subject of a number of research analyst reports. Credit Suisse Group initiated coverage on shares of Clorox in a report on Wednesday, March 6th. They issued an “outperform” rating and a $172.00 price target for the company. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 price target for the company in a report on Monday, March 11th. JPMorgan Chase & Co. downgraded shares of Clorox from a “neutral” rating to an “underweight” rating and cut their price target for the company from $159.00 to $139.00 in a report on Monday, April 8th. Deutsche Bank upgraded shares of Clorox from a “sell” rating to a “hold” rating and set a $139.00 target price for the company in a report on Thursday, May 2nd. Finally, Citigroup dropped their target price on shares of Clorox from $171.00 to $160.00 and set a “neutral” rating for the company in a report on Thursday, May 2nd. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $149.29.

In other Clorox news, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the transaction, the senior vice president now directly owns 4,896 shares of the company’s stock, valued at $771,658.56. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 1.40% of the company’s stock.

Shares of CLX traded up $0.84 during mid-day trading on Friday, hitting $153.11. The company had a trading volume of 1,228,773 shares, compared to its average volume of 878,949. The business has a 50-day moving average of $151.98. The company has a current ratio of 1.10, a quick ratio of 0.66 and a debt-to-equity ratio of 2.93. Clorox Co has a 1-year low of $127.34 and a 1-year high of $167.70. The company has a market cap of $19.50 billion, a PE ratio of 24.46, a PEG ratio of 4.43 and a beta of 0.38.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.03). The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period last year, the firm earned $1.37 earnings per share. Research analysts forecast that Clorox Co will post 6.29 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st will be given a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a yield of 2.77%. This is a boost from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. Clorox’s payout ratio is 61.34%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Correction

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.